Avanafil 200 MG Oral Tablet — RxCUI 1291365
RxNorm drug concept · Semantic clinical drug
RxCUI 1291365
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1291365
Official nameAvanafil 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Avanafil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Stendra (avanafil) is one of the faster-acting options in its class — it can start working as early as 15 minutes after you take it. That said, you still need sexual stimulation fo...
- How quickly does avanafil work, and how long does it last?
- It depends on which ones. If you take any nitrate medication — like nitroglycerin tablets, patches, or sprays — you absolutely cannot take avanafil. The combination can drop your b...
- Can I take avanafil with my heart medication or blood pressure pills?
🕸️ Concept Web — How Avanafil 200 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Avanafil 200 MG Oral Tablet
RxCUI 1291365 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Avanafil
1291301IN
-
Avanafil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Stendra
1291307BN
-
Stendra
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Avanafil Oral Tablet
1291305SCDF -
Avanafil Oral Product
1291303SCDG -
Avanafil Pill
1291304SCDG -
Avanafil Oral Tablet [Stendra]
1291309SBDF -
Stendra Oral Product
1291310SBDG -
Stendra Pill
1291311SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Avanafil Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Avanafil 200 MG
1291364SCDC -
Avanafil 200 MG Oral Tablet [Stendra]
1291367SBD -
Avanafil 200 MG [Stendra]
1291366SBDC
-
Avanafil 200 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Avanafil 200 MG
SCDC · 1291364 -
Avanafil Oral Tablet
SCDF · 1291305 -
Avanafil Oral Product
SCDG · 1291303 -
Avanafil Pill
SCDG · 1291304
Brand-Name Concepts
-
Avanafil 200 MG Oral Tablet [Stendra]
SBD · 1291367 -
Avanafil 200 MG [Stendra]
SBDC · 1291366 -
Avanafil Oral Tablet [Stendra]
SBDF · 1291309 -
Stendra Oral Product
SBDG · 1291310 -
Stendra Pill
SBDG · 1291311 -
Stendra
BN · 1291307
📦 FDA Products & Package NDCs
3 products · 6 package NDCs
6 package NDCs map to RxCUI 1291365 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 31722-0440-01 | 100 TABLET in 1 BOTTLE (31722-440-01) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
| 31722-0440-30 | 30 TABLET in 1 BOTTLE (31722-440-30) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
| 31722-0441-01 | 100 TABLET in 1 BOTTLE (31722-441-01) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
| 31722-0441-30 | 30 TABLET in 1 BOTTLE (31722-441-30) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
| 31722-0442-01 | 100 TABLET in 1 BOTTLE (31722-442-01) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
| 31722-0442-30 | 30 TABLET in 1 BOTTLE (31722-442-30) | Avanafil | Camber Pharmaceuticals, Inc. | 2024-06-14 |
Observed labelers:
Camber Pharmaceuticals, Inc. (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.